Literature DB >> 20802957

[Amyloidosis and end-stage renal disease associated with leprosy].

Geraldo Bezerra da Silva Júnior1, Orivaldo Alves Barbosa, Roseanne de Moura Barros, Priscila Dos Reis Carvalho, Talita Rodrigues de Mendoza, Dulce Maria Sousa Barreto, Célio Araújo Barboza, Antônio Augusto Carvalho Guimarães, Elizabeth de Francesco Daher.   

Abstract

Renal involvement in leprosy includes glomerulonephritis, amyloidosis and tubulointerstitial nephritis. A 58-year-old man was admitted with complaints of lower limb edema and dyspnea. At admission, nitrogen retention, anemia, hyperkalemia and metabolic acidosis were observed, requiring hemodialysis. The patient had a history of lepromatous leprosy. A renal biopsy was performed that was compatible with amyloidosis. The patient had a stable outcome, but without renal function recovery and remained on regular hemodialysis. Leprosy should be investigated in every patient with renal function loss, particularly in those with cutaneous lesions or other manifestations suggestive of leprosy.

Entities:  

Mesh:

Year:  2010        PMID: 20802957     DOI: 10.1590/s0037-86822010000400031

Source DB:  PubMed          Journal:  Rev Soc Bras Med Trop        ISSN: 0037-8682            Impact factor:   1.581


  3 in total

Review 1.  Leprosy nephropathy: a review of clinical and histopathological features.

Authors:  Geraldo Bezerra da Silva Junior; Elizabeth De Francesco Daher; Roberto da Justa Pires Neto; Eanes Delgado Barros Pereira; Gdayllon Cavalcante Meneses; Sônia Maria Holanda Almeida Araújo; Elvino José Guardão Barros
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2015 Jan-Feb       Impact factor: 1.846

2.  Serum Interleukin 6 Level and Nutrition Status as Potential Predictors of Clinical Leprosy Development Among Household Contacts in Endemic Areas.

Authors:  Salma Oktaria; Fatih Anfasa; Sri Linuwih Menaldi; Kusmarinah Bramono; Tamar E C Nijsten; Hok Bing Thio
Journal:  Open Forum Infect Dis       Date:  2022-02-02       Impact factor: 3.835

3.  Leprosy: a review of laboratory and therapeutic aspects--part 2.

Authors:  Joel Carlos Lastória; Marilda Aparecida Milanez Morgado de Abreu
Journal:  An Bras Dermatol       Date:  2014 May-Jun       Impact factor: 1.896

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.